2nd API Crystallization Workshop
Dr. Judith Aronhime
Independent scientific consultant in the fields of pharmaceutical polymorphism and solid-state chemistry.
IP litigation support professional.
21st January 2021
Expert in pharmaceutical polymorphism. Spent 27 years at Teva as head of solid-state characterization within TAPI global R&D.
Focused on all the aspects of the active pharmaceutical ingredients where polymorphism is industrially relevant like novel forms screenings, analyses, characterization, development, and registration.
Gained broad experience in providing scientific support to patent litigations related to crystal forms, as well as prosecutions, clearances, and oppositions. Key contributor to TEVA worldwide leadership position in the intellectual property domain by searching new crystal forms of APIs and creating valuable IP. Author of and contributor to more than 100 patents. Took a dominant role in assessing IP strategies.
Author of a chapter in the book “Solid State Development of Pharmaceutical Molecules. Salts, Cocrystals, and Polymorphism”, ed. Michael Gruss, Wiley-VCH (to be published in 2021).
Obtained a Ph.D. in Applied Chemistry at the Hebrew University of Jerusalem.